Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gene interaction linked to schizophrenia
The researchers developed a model of schizophrenia that provides a way to study and understand how the loss of both Prodh and Comt gene activity contributes to the
The researchers developed a model of schizophrenia that provides a way to study and understand how the loss of both Prodh and Comt gene activity contributes to the
The drug will compete with Pfizer’s Viagra, Lilly’s Cialis, and Bayer/GSK’s Levitra for a share of the estimated $100 million erectile dysfuntion market in Korea. Various phase II
Avelox is the only marketed fluoroquinolone antibiotic approved by the FDA as monotherapy to treat this indication. The FDA approval for this disorder is the sixth indication for
Paliperidone ER uses OROS technology, which releases drug into the bloodstream steadily over a 24-hour period. Upon FDA approval, the drug will be marketed in the US by
The trial is designed to evaluate clinical safety of SB-509 in diabetics with mild to moderate diabetic peripheral sensory motor neuropathy in both legs. Twelve subjects have been
The new drug application (NDA) is based on data generated by a number of studies incorporating 11 pharmacokinetic studies and five phase III clinical studies. The five phase
Aastrom’s tissue repair cell (TRC) product, a proprietary bone marrow-derived adult stem cell product, will be used in posterior-lateral lumbar spinal fusions for treatment of degenerative spondylolisthesis. This
The parties will work to advance the state of the science in the field of orthopedics through collaborative research and education. The research will include, but not be
In an international, controlled clinical trial, subjects with bacterial conjunctivitis (pink-eye) were treated with either AzaSite dosed twice a day for the first two days, followed by once
Under the agreement, IntelliPharmaCeutics will develop the controlled release product, and Par will submit the abbreviated new drug application (ANDA) to the FDA and provide regulatory and legal